Abstract:Background: Severe brain injury significantly influences immune responses. However, the levels at which such influence occur and the involvement of neurogenic pathways are not well defined. Methods: 39 eligible patients with supratentorial ICH within 24 hours of onset and 20 matched healthy controls were enrolled. Hematoma sizes at admission were calculated via computed tomography (CT). Perihematomal edema (PHE) and spleen volume at day 3 and 14 were measured via T2-weighted magnetic resonance imaging (MRI), respectively. Tissue diffusion and capillary perfusion of spleen were quantified by Intravoxel incoherent motion diffusion-weighted imaging (IVIM-DWI) with 9 b values. Peripheral lymphocyte subsets were quantified by flow cytometry. Neurotransmitters and stress hormone were detected by enzyme-linked immunosorbent assay (ELISA). Association of splenic and cellular alterations with progression of PHE and the outcomes of ICH patients were analyzed. Mechanisms governing the spleen and lymphocyte alterations after ICH were investigated in mouse models of ICH. Results: Average spleen shrinkage of 37ml accompanied by splenic capillary perfusion increase occurred in ICH patients at day 3 after disease onset. The magnitude of spleen shrinkage was associated with hematoma size upon admission. Concurrently, patients with severe spleen shrinkage (> 37ml) had less progression of PHE. Lymphopenia was observed in ICH patients after ictus and persisted up to 14 day, which was not parallel with spleen alteration. Patients with infections exhibited poorer functional outcome and significant T and NK cell deficiency. In ICH models, signals derived from adrenergic and hypothalamus-pituitary-adrenal (HPA) axis activation contributed to loss of white blood cells in the white pulp. Conclusions: Spleen shrinkage and lymphopenia reflect the impact of ICH on the immune system at the organ and cellular levels, such impacts are derived from coordinated action of sympathetic innervation and HPA axis. The magnitude of spleen shrinkage might be associative with the progression of PHE and clinical outcome of ICH patients. Additionally specific cellular immunity deficiency was associated with increased infection risk in patients.

Sepsis-Exacerbated Brain Dysfunction after Intracerebral Hemorrhage

Association Between Systemic Inflammatory Response Syndrome and Hematoma Expansion in Intracerebral Hemorrhage.

Sepsis and Cerebral Dysfunction: BBB Damage, Neuroinflammation, Oxidative Stress, Apoptosis and Autophagy as Key Mediators and the Potential Therapeutic Approaches

Systemic immune responses after ischemic stroke: From the center to the periphery

Sepsis-Induced Brain Dysfunction: Pathogenesis, Diagnosis, and Treatment

Current Understanding of Long-Term Cognitive Impairment after Sepsis

The Key Drivers of Brain Injury by Systemic Inflammatory Responses after Sepsis: Microglia and Neuroinflammation

Acute and long-term cognitive impairment following sepsis: mechanism and prevention

The Advance of Pathogenesis of Sepsis-Associated Encephalopathy

Sepsis-associated brain injury: underlying mechanisms and potential therapeutic strategies for acute and long-term cognitive impairments

The role of the peripheral system dysfunction in the pathogenesis of sepsis-associated encephalopathy

Neurochemical effects of sepsis on the brain

Sepsis-associated encephalopathy: a vicious cycle of immunosuppression

Organ- and Cell-Specific Immune Responses Are Associated with the Outcomes of Intracerebral Hemorrhage.

Neuroimmune Regulation in Sepsis-Associated Encephalopathy: The Interaction Between the Brain and Peripheral Immunity

Gut Microbiota Dysbiosis Induced by Intracerebral Hemorrhage Aggravates Neuroinflammation in Mice

Targeting the Blood-Brain Barrier to Prevent Sepsis-Associated Cognitive Impairment

Pathogenesis of sepsis-associated encephalopathy: more than blood–brain barrier dysfunction

Immune-mediated disruption of the blood-brain barrier after intracerebral hemorrhage: Insights and potential therapeutic targets

Progress of cognitive dysfunction after sepsis

[Research progress on the changes of blood-brain barrier in sepsis-associated encephalopathy]